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Abstract
Objective—Previous intervention research conducted in Appalachian Kentucky resulted in 
extremely low uptake and adherence to the human papillomavirus (HPV) vaccine among women 
ages 18 –26, despite provision of free vaccine. Because of these findings, the purpose of this 
qualitative, follow-up study was to elicit health care providers' perspectives on barriers and 
facilitators to HPV vaccination and suggested strategies for improving vaccination rates.
Design and Sample—Researchers conducted semi-structured qualitative interviews with a 
purposive sample of eight health care providers (seven nursing professionals, one physician) at the 
health clinic where the original HPV vaccination intervention took place. Interviews were audio-
recorded and transcribed and authors used a constant-comparative method to analyze the data.
Results—Significant themes emerged from the interviews, centering around two primary issues: 
vaccine uptake and vaccine adherence. Related to uptake, health care providers identified 
perceived patient barriers and inadequate HPV vaccine education. They also identified the vaccine 
schedule and clinic-centered communication deficiencies as adherence-related barriers.
Conclusion—These Appalachian Kentucky health care providers provided important insights 
into barriers and facilitators to HPV vaccine uptake and adherence that need to be readily 
addressed in this community. As informed by these providers, several suggestions for improving 
HPV vaccination, such as more targeted education efforts and patient-centered reminder systems, 
may be applicable to other nursing professionals working in rural and medically underserved 
communities.
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Uptake and adherence to the three-dose human papillomavirus (HPV) vaccine remains low, 
which is particularly concerning for communities that shoulder an excessive burden of 
cervical cancer and have limited access to health care, such as Appalachian Kentucky. A 
previous intervention study conducted in this geographic region revealed low HPV 
vaccination rates among young women ages 18–26, despite waiving the cost of the vaccine 
series. The current study serves as a qualitative follow-up to this previous intervention 
research, seeking to understand health care providers’ perspectives on actual barriers and 
facilitators to HPV vaccination and garnering strategies for improving vaccination rates in 
this region.
Background
Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) and 
the leading cause of cervical cancer (Advisory Committee on Immunization Practices, 2010; 
Centers for Disease Control and Prevention [CDC], 2010). Two HPV vaccines have been 
developed—Gardasil (Merck) and Cervarix (GlaxoSmithKline) to protect against infection 
from HPV types 16 and 18 which are responsible for 70% of all cervical cancers (Advisory 
Committee on Immunization Practices, 2010; Markowitz et al., 2007; National Cancer 
Institute [NCI], 2009). Gardasil also protects against HPV types 6 and 11 which cause 90% 
of genital warts (NCI, 2009). The vaccines are approved for females ages 9–26, with 
recommendations to vaccinate adolescent girls before becoming sexually active (CDC, 
2010; Markowitz et al., 2007). Despite these national guidelines, uptake rates of the HPV 
vaccine are low. The 2010 National Immunization Survey revealed that only 53% of girls 
ages 13–17 have received dose one, and only 35% have completed three doses (CDC, 
2012b). In Kentucky, a state recognized for cervical cancer disparities (Hopenhayn, King, 
Christian, Huang, & Christian, 2008; Lengerich et al., 2005), only 46% of girls ages 13–17 
have received at least dose one (CDC, 2012b). Vaccination rates are especially low for older 
females. Nationally, self-reported uptake rates for all three doses among women ages 19–26 
is only 21% (CDC, 2012a). In addition to differences in uptake and adherence among age 
groups, disparities have been noted among racial and ethnic groups (e.g., Hispanic, African 
Americans), patients who receive the vaccine through public funding, and females who live 
in poverty and neighborhoods with lower levels of education (CDC, 2012b; Chao, Velicer, 
Slezak, & Jacobsen, 2010; Cook et al., 2010; Tan et al., 2011).
HPV vaccination research is germane in the Appalachian region of the United States, where 
cervical cancer rates are elevated (Huang et al., 2002; Wingo et al., 2008; Yabroff et al., 
2005), suggesting a higher prevalence of oncogenic HPV infections. Specifically, 
Appalachian Kentucky suffers from poor socioeconomic conditions, higher cervical cancer 
incidence and mortality, lower screening rates, low HPV vaccination rates, geographic 
isolation, and limited health care services (Appalachian Regional Commission [ARC], 2008; 
Behringer & Friedell, 2006; Couto, Simpson, & Harris, 1994; Hopenhayn et al., 2008; 
Huang et al., 2002; Reiter, Katz, & Paskett, 2012; Wingo et al., 2008).
Although much attention has focused on young women’s perceptions of the HPV vaccine 
and their vaccination decisions (Fazekas, Brewer, & Smith, 2008; Hall, Howard, & 
McCaffery, 2008; Short et al., 2010; Wang, Simoni, & Wu, 2006), little research has 
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focused on rural health care providers’ perceptions (Katz, Reiter, Heaner et al., 2009; Katz, 
Reiter, Kennedy et al., 2009; Keating et al., 2008). The perceptions of nursing professionals 
are particularly important as previous research suggests most nurses are supportive of HPV 
vaccination and are in an ideal position to provide related HPV education to young women 
compared to other clinicians (Duval et al., 2008; Teitelman, Stringer, Averbuch, & 
Witkoski, 2009). In rural locales, it is important to hear from nursing staff as these providers 
help offset physician shortages in geographically isolated communities (Gamm, Castillo, & 
Pittman, 2003). Further, nursing professionals play a variety of professional and personal 
roles in rural areas including a formal caretaker, neighbor, church member, community 
stakeholder, and friend (Long & Weinert, 2010). Nursing professionals, especially, play a 
key role in HPV vaccination decisions (Chao et al., 2010; Rosenthal et al., 2010; Teitelman 
et al., 2009) and may offer important perceptions of patient health that differ from the 
patients themselves (Fitzgerald et al., 2008). In summary, the literature is lacking 
perspectives from rural health care providers, particularly from rural nursing professionals, 
on cervical cancer prevention through HPV vaccination; this group of providers may 
provide important insights for improving this important public health behavior.
Research questions
The purpose of this study was to address this gap in the literature by seeking to understand 
health care providers’ perspectives on HPV vaccination uptake and adherence in rural 
Appalachian Kentucky. Specifically, this work served as a qualitative follow-up to research 
conducted by Crosby, Casey, Vanderpool, Collins, and Moore (2011) which compared HPV 
vaccination rates (specifically, Gardasil) among females ages 18–26 in Appalachian 
Kentucky to an urban Kentucky sample. Those researchers found that young rural women 
were significantly less likely to return for subsequent doses of the HPV vaccine compared to 
their urban counterparts. This finding was noteworthy, given that the vaccine series was 
offered free of charge to all participants (vaccine costs were covered by the original Crosby 
et al. study’s grant funding). Of the 246 rural clinic-recruited women, only 45% initiated 
dose one. Furthermore, only 14% of those who received dose one returned for dose two and 
only 5% received dose three (Crosby et al., 2011).
As an extension of the Crosby et al. (2011) quantitative findings, we sought in this study to 
engage health care providers who were familiar with the previous research in in-depth 
conversations to elicit their perspectives on why uptake and adherence rates were minimal 
among their young adult female population when considering cost had been removed as a 
barrier to vaccination. In addition, we sought to solicit suggestions for strategies to improve 
HPV vaccination rates in their community.
Methods
In consultation with both the principal investigator of the previous HPV vaccination 
intervention and the director of the rural, Federally Qualified Health Center (FQHC) where 
the intervention took place, the research team designed a study protocol which invited health 
care providers (e.g., nursing professionals, physicians) to participate in semi-structured, in-
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depth interviews. The study protocol was approved by the University of Kentucky’s 
Institutional Review Board.
Design and sample
Formal invitation letters were sent to all health care providers (N = 15; six licensed practical 
nurses, three nurse practitioners, six physicians) on staff at the regional FQHC which served 
as the primary rural study site in the original Crosby et al. intervention. Given the variety of 
medical professions represented in this sample, we use the term “health care providers” 
broadly to encompass all our study participants. Eight individuals (53% response rate) 
agreed to participate in the current qualitative study and each received $75 for their 
participation. See Table 1 for participant demographics and professional qualifications.
The interviews were conducted in May 2010 and took place in a private room at the FQHC; 
each interview lasted approximately 1 hr. Participants provided informed consent before the 
interview began. The interviewer (second author) followed a semi-structured interview 
protocol informed by an in-depth review of the HPV vaccine literature (Brewer et al., 2007; 
Katz, Reiter, Heaner et al., 2009; Katz, Reiter, Kennedy et al., 2009; Rosenthal et al., 2010), 
as well as the quantitative findings of Crosby et al. (2011). Related, the interviewer 
presented a line graph (see Fig. 1) generated from the Crosby et al. intervention to prompt 
study participants in conversation about why vaccine uptake and adherence rates would be 
so low for these young adult women from the surrounding rural community.
Interview questions specifically focused on health care providers’ perceptions of barriers 
and facilitators to HPV vaccination uptake and adherence. For example, questions inquired 
about religious, familial, peer, and socioeconomic influences on women’s vaccination 
decisions as well as patients’ general understanding of HPV, HPV-related diseases, and the 
value of the vaccine. In addition, questions addressed potential issues related to non-
compliance with the full vaccine series (e.g., transportation, clinic reminder systems, and 
clinic appointment protocols). Participants were specifically asked to a) focus on the 
communication interactions that take place with their patients at the point of care (i.e., 
discussion on HPV and cervical cancer prevention with their patients) and b) articulate 
changes, strategies, and/or approaches that would help eliminate barriers to HPV vaccination 
uptake and adherence, thereby improving overall vaccination acceptance and compliance. 
Each session was audio-recorded and transcribed verbatim. Participants were given a 
pseudonym which corresponded with the order in which the interviews were conducted 
(HP1 = Health Care Provider Interview 1).
Analytic strategy
This study used a constant-comparative method to analyze the data (Lindlof & Taylor, 2002; 
Schoenberg, Hatcher, & Dignan, 2008; Strauss & Corbin, 1990). All three authors read the 
transcripts line-by-line and generated initial codes through code notes and analytic memos. 
The authors then met to discuss these initial findings and develop more comprehensive 
categories; this led to the development of a codebook. The first author returned to the 
transcripts and coded them using the generated codebook, gathering key exemplars for each 
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emerging finding. All three authors met repeatedly to discuss the findings to resolve any 
discrepancies and come to consensus about coding and interpretations of data.
The research team did not use qualitative analysis software due to the limited number of 
transcripts; however, three steps were taken to ensure rigor in the data analysis. First, the 
research team has previous research experience working with Appalachian Kentucky 
residents and with this rural FQHC in particular; this allowed the researchers to evaluate the 
findings based on their past experiences in the field. Findings were also discussed with the 
authors of the original HPV vaccination intervention; this team consists of public health 
practitioners, academic researchers, and clinicians. Second, the research team has members 
from three different disciplines (e.g., health communication, public health, and cancer 
control) which allowed for multiple perspectives during the coding and interpretation of 
data. Third, saturation was reached with just these eight participants; these women voiced 
strikingly similar perspectives on this topic which was not surprising given their related 
backgrounds and that they serve the same patient population.
Results
Before discussing the larger emergent themes from the data, two small, though significant, 
findings are worth noting. First, five HPs acknowledged the high rates of abnormal Pap 
tests, HPV infections, genital warts, and related treatment procedures they see in this rural 
Kentucky region. HP1 explicitly noted, “[it’s] getting so widespread, it’s out of control.” 
Second, six HPs voiced strong personal confirmation in the efficacy of the vaccine and 
indicated that they use their personal beliefs when discussing it with their patients. 
Specifically, three HPs indicated that they would obtain the vaccine if they were age-
eligible. These initial findings provide the reader with an understanding of the HPs’ 
experience with cervical-related health issues among their patients and provide tangible 
evidence of their support for protecting women against HPV infection.
The main themes of this qualitative study are grouped into two categories. First, HPs 
identified reasons they believed there was low vaccine uptake (dose one) in this rural area. 
Specifically, these rural HPs identified specific patient barriers to HPV vaccination and 
inadequate HPV vaccine education in the community. Second, HPs identified reasons they 
believed there was low vaccine adherence (doses two and three) among those women who 
initiated the vaccine series. Specifically, these rural HPs acknowledged patient beliefs about 
the inconvenience of adhering to the three-dose vaccine schedule and clinic-centered 
communication deficiencies. Within each theme, HPs detailed barriers, but were also 
prompted to provide suggestions for overcoming these barriers in their rural clinic 
population. Each theme is presented below.
Reasons for low HPV vaccination uptake
Patient barriers to vaccination—The HPs identified two reasons why patients in their 
clinic population do not receive dose one. First, they believed that young women are reticent 
to receive the vaccine because “they just do not want to have a shot” (HP5) and “the pain of 
the shot” (HP6). This was especially the case when trying to understand why women in the 
intervention study did not come in even when cost was eliminated as a barrier. HP5 
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compared those findings to females in younger age groups (9–17 years old) where she 
thought “it would probably be more parents not wanting their child to have the shot” and 
went on to say that “in the older population…that makes their own decisions, I would think 
it would be just not getting a shot.” HP3 believed the pain from the initial shot makes some 
patients she sees “real reluctant to…get the [next] dose even when they are there for their 
next scheduled follow-up.” HP1 acknowledged to her patients that while the shot does burn, 
“it is only going to last, you know, a minute and [it will] be over with.” HP7 emphasized to 
her patients “if they get the disease…warts…letting us take stuff or do colopos…then that is 
painful compared to the shots.”
The second reason (or, patient barrier) is that HPs believed young women from this area do 
not believe the HPV vaccine is important to their health. For instance, HPs voiced that many 
of their patients do not understand the link between this STI and cervical cancer and 
therefore do not believe they need to take steps to protect themselves from HPV. Five HPs 
stressed with their patients how HPV is the most common STI in the United States but 
interestingly, HP8 noted that many women are more worried about other sexually 
transmitted diseases. She said “you never hear a patient say, I think I have HPV…since the 
research started, we became more knowledgeable and more apt to talk to them about 
[HPV].” HP8 emphasized to her patients how easily HPV is spread without a person even 
knowing it; she tells her patients “you may never know where you got it…but you will have 
a remembrance from now on.” Despite media coverage, even basic awareness of the vaccine 
is low in this area, as HP3 said that “a lot of folks just do not know what that [HPV] is.” 
HP1 stresses the importance of the HPV vaccine by educating young women about how 
“you never know that the guy has it until it is too late, until you have that abnormal Pap 
smear. So just educating them on how it’s transmitted” and that the HPV vaccine is “one of 
the ways that we can prevent that…[then] they seem very, very interested.”
Related, HPs also indicated that they have few women proactively ask for the vaccine. HP8 
said “I have very few patients that actually come in and ask for the vaccine; that is 
something that I bring up to the patients; they do not a lot of times mention that.” HP1 also 
said that her patients rarely bring up the vaccine and estimates that there are maybe “ten that 
is ever brought it up.” HP5 said that while “I do not think that most people refuse it when we 
offer it,” it is the HPs who must be proactive in offering the vaccine to the patient. In 
addition, she said that “most of them really take whatever they get for free…they do not ask 
a lot of questions.” She went on to say that “they may not even know, understand what it is 
but they will take it.” This implies that some women are receiving the HPV vaccine without 
fully understanding what it is for and how important it is to their health.
Inadequate region- and age-specific HPV vaccination education and 
promotion—HPs believed that increased patient education about the vaccine is needed, 
especially through more focused media efforts for rural Appalachian Kentucky that 
generates discussion throughout the community such as billboards, radio, and community 
events. HP1 commented that informational videos playing at pharmacies and clinic lobbies 
would help to educate a variety of people about the vaccine, including mothers and 
grandmothers, who according to half of the providers, still play an important role in young 
adult women’s health care decisions. She suggested a video because “a lot of people cannot 
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read in this area…they need the hands-on education and visual” offered in a video format. 
This statement was countered by six other HPs who identified text-based pamphlets as 
important education tools they use with patients. In addition, several HPs believed that the 
current HPV media campaign (e.g., Merck’s “One Less” campaign) is not focused on these 
young adult women (HP3 said “it looks like it is for children”) and a separate campaign “to 
market [to] the older adolescent group” (HP1) is needed. HP5 argued that “probably not as 
many of them realize that they are candidates for the vaccine” because of the focus on 
younger girls. In addition, HP1 argued that the current HPV vaccine commercials “may be 
perceived as sex being ok if they obtain the vaccine and many religions in the area I know 
would have problems with that.” HP5 also commented that religion may play a role in 
Appalachian Kentucky “more so than other [areas] because we are still kind of the Bible 
Belt area.” As a result of the national campaign’s mismatch with this older age group and 
geographic region, HP4 stated that in turn it is the local HPs’ responsibility to promote the 
vaccine to this older age group. Related, HP1 went on to say that “the lack of health care in 
the area provides less patient education so we spend a lot of time trying to educate these 
patients.”
In addition to more targeted efforts for this young adult population in Appalachian 
Kentucky, several HPs advocated for a focus on genital warts which are also a sequelae of 
HPV infection. HP7 noted that one of the HPV vaccines (Gardasil) prevents “not just 
cervical cancer…but genital warts, which are something that as I tell the kids you know, 
when you get that, you have got it the rest of your life; you may never where you got it and 
you would not know his name.” HP6 said that many anti-smoking campaigns geared toward 
this age group are “geared toward how ugly it is and like visual things”, so for HPV, it might 
be effective “if you could have these big old warts.” HPs felt that a focus on genital warts 
would make the vaccine more relevant for this age group, thereby potentially increasing 
uptake.
Reasons for low HPV vaccination adherence
Complications of three-dose vaccine schedule—HPs identified two reasons why 
patients do not return for doses two and three of the HPV vaccine; current ACIP guidelines 
promote receipt of all three doses (CDC, 2010). First, they believed that many of the young 
women they see do not understand the importance of the full vaccine series and this is 
coupled with the inconvenience of coming back to the clinic for the two remaining shots. 
HP8 argued “I do not think in this age group, they do not value the importance of the 
immunization.” HP8 believed that it “looks like there is a breakdown in terms of stressing 
the importance of coming back” and HP2 said that “of course it needs to be stressed that it 
takes all three doses to be effective,” indicating that these HPs believe that some of the 
responsibility for vaccine adherence lies with the provider who administers the first dose. 
Several of the HPs said they inform their patients of the importance of and commitment to 
the three-dose regimen during the first visit because of the difficulty in getting them back for 
subsequent injections. HP8 said “that is the hard part. I usually start by saying you know 
there is no use in you taking the first dose if you are not going to come back.” She went on 
to say “…do not just take this because you are here today and I am looking at you and you 
feel obligated to take this…make the commitment to come back.” HP8 also recalled some 
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patients commenting that because they have received dose one, they do not need to receive 
doses two and three. Similarly, HP2 stated, “maybe they think that after the first dose, 
maybe they are okay”. HP3 believed her patients think “I had one, why do I need three?” 
This is another example of these rural HPs’ perceptions that the young women they serve 
may not understand the value of preventive immunization and are not making fully informed 
decisions when initiating the vaccine series.
When women come back to the clinic for something else, the HPs often followed up on their 
completion of the vaccine series. HP5 said that she has “had a few of those where they came 
in; I am like, have you had your Gardasil? Yeah, yeah. I was like did you have all of it? No, 
I only had one dose and it was like 7 months ago so.” She said that for patients in similar 
situations, they have made the clinical decision to restart the vaccine series, which is costly 
and only adds to the discomfort a woman may experience (i.e., having to receive even more 
shots than the normal three-dose regimen). The medical decision to revaccinate is not taken 
lightly; if the woman received her initial shot(s) elsewhere, the provider may not have access 
to her immunization records, becoming solely reliant on potentially inaccurate patient self-
report.
Clinic-centered communication deficiencies—HPs identified three key areas of 
communication that they believe would improve HPV vaccine adherence for the young adult 
women they serve. First, these HPs believed there were many missed opportunities for HPV 
vaccination in their clinic. They suggested simple policy changes which target women at 
varying interactions with the health care system such as adding a question about HPV 
vaccination status in primary care clinic “in-take” forms (HP3), making HPV vaccination a 
standing physician order (i.e., similar to influenza and pneumonia vaccinations) during 
routine primary care visits (HP3); inquiring about HPV vaccination status during OB/GYN 
and family planning visits (HP2, CP5, HP8), college physicals (HP4), and/or young mothers 
attending well-child visits (HP5). By questioning women about HPV vaccination at any 
these points, it increases the possibility of having higher vaccine adherence rates and thus 
providing the full protection from HPV afforded by this vaccine.
Second, the HPs in our study overwhelmingly believed a more effective clinic reminder 
system is needed to increase adherence rates. Several HPs identified reminder card systems, 
but as HP8 noted “you know, those get lost.” Instead, she believes something like “text 
messages would probably be right up there with that group.” HP2 also believes cell phones 
would be effective if used in a reminder system because these women always have their cell 
phone on their person and will “walk in texting and talking on the cell phone” even in the 
doctor’s office. Some HPs also suggested email as an effective means for reminders. 
However, while HP1 recognizes that technology is definitely an effective communication 
tool, she advocates communicating with the patient about her preferences for reminders as 
the best strategy for improving vaccine adherence: “ask the patient how she want[s] 
reminded.”
Third, HPs believed increased knowledge and awareness of the vaccine appointment 
protocol was important to improve vaccine adherence. HP8 said some women “generally 
associated coming to the clinic with a 2–3 hr process” when in reality women can “just pop 
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in and get it done and you’re out the door” because they do not need to see a doctor when 
receiving the second and third dose. HP2 also said that the convenience of seeing only a 
nurse for doses two and three—without an appointment—needs to be clearly explained at 
the first dose. This was echoed by other HPs in the study, emphasizing the need for 
improved communication about clinic vaccine appointment protocol.
Discussion
The results from this study offer insight into rural health care providers’ perceptions of both 
barriers and facilitators to improving HPV vaccine uptake and adherence among young adult 
women. Among the many valuable suggestions provided by participants in this study, there 
are four specific recommendations for practice that are worth highlighting.
First, health care providers may need to be more proactive about recommending the vaccine 
to all their eligible patients, especially considering providers in this study suggest that 
patient requests are minimal. Similarly, Keating et al. (2008) reported that almost 60% of a 
sample of rural North Carolina medical practices were concerned that too few patients 
wanted the vaccine. HPs in this study identified multiple time points when young women 
may interact with the health care system in their clinic, providing an opportunity to offer the 
initial HPV vaccination or subsequent doses. Unfortunately, research also reveals that 
pediatricians serving younger females in Appalachia are less likely to encourage HPV 
vaccination compared to non-Appalachian pediatricians (Krieger, Katz, Kam, & Roberto, 
2012). This suggests that nursing professionals serving young adult female patients, like 
those in our study, may have an even heavier burden to bear when it comes to encouraging 
HPV vaccination for this patient group. Improvements in targeting all age-eligible patients 
for the vaccine, particularly young adult women, must be coupled with communication 
emphasizing the importance of the vaccine and the commitment to complete the three-dose 
series. The lack of understanding of the importance of this preventive health measure was 
pervasive in the providers’ perceptions of barriers to both HPV vaccine uptake and 
adherence. Our findings echo Teitelman et al. (2009) in suggesting health care providers, 
especially nursing professionals, have a role in not only helping patients make an informed 
decision about starting the HPV vaccine, but encouraging completion of the entire series.
Second, participants in our study believed more tailored, age-appropriate and region-specific 
promotional campaigns for young women are needed in Appalachian Kentucky. Merck’s 
“One Less” campaign was originally targeted to the mothers of young girls and may have 
failed to address women ages 18–26; this is echoed by the present findings. Subsequently, 
many of the providers felt like a different approach is needed to reach this young adult 
population. Several recommended more graphic campaigns showcasing genital warts caused 
by HPV as a prompt to vaccination, instead of the more common message of preventing 
cervical cancer. Furthermore, a heavier reliance on local media such as billboards, radio, and 
community events may emphasize the benefits of receiving the vaccine for this catch-up 
group of women and make the issue more salient for those young adult women who have 
little to no awareness of their eligibility to receive the vaccine.
Head et al. Page 9
Public Health Nurs. Author manuscript; available in PMC 2016 February 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Third, more synchronized and effective reminder systems may be needed. Many of the 
providers in our study mentioned an appointment card or phone call is used as a reminder 
for the next HPV vaccine dose; however, these remain ineffective as adherence is low. 
Perhaps the most important piece of a reminder system is the patient-centered approach. 
Simply asking women which reminder method is preferred could help increase adherence, 
especially with today’s variety of technology options. Several providers recommended cell 
phone (specifically, text message) reminders, which represents an effective communication 
system that clinics can easily implement (Head, Noar, Iannarino, & Harrington, 2012).
Fourth, providers in this study felt one of the reasons patients fail to return for doses two and 
three is because they do not want to make an appointment and wait at the clinic for the 
simple act of receiving an injection. This could imply poor communication of the clinic’s 
vaccination appointment protocol to patients; clinics should advertise that the subsequent 
doses may not require an actual physician appointment, but rather a nurse-only visit. This 
strategy may encourage young adult women to return to the clinic for the follow-up doses. 
In Appalachian Kentucky, this is particularly relevant because transportation to and from the 
health clinic may be difficult and therefore it is important to emphasize the convenience of a 
nurse-only visit.
There were several limitations of this study. First, there is limited generalizability as this 
study employed a small sample and focused only on rural health care providers serving 
young adult women in Appalachian Kentucky. Despite recruitment efforts, many factors 
may have contributed to the small sample size such as nurses’ and physicians’ busy 
schedules and time constraints. However, it should be noted that, though the sample size is 
small, these eight individuals—through the services of the FQHC where they are employed
—actually provide a substantial portion of women’s and primary care-related health care in 
the eight-county vicinity. In addition, they were able to offer detailed and meaningful insight 
into the low vaccine uptake and adherence rates for the population of patients from the 
previous intervention study conducted at their FQHC. Second, the current research team 
shares an institutional affiliation with the FQHC; however, the researchers did not 
personally know any of the clinic staff prior to the interview. Regardless, there may have 
been undue bias with a university-based professor (second author) conducting the 
interviews. Third, the study sought to understand health care providers’ perspectives of low 
HPV vaccine uptake and adherence in their patient population. This represents a form of 
others’ reports that comes with its own limitations; for this study, that might include 
inaccurate observations and biased interpretations of patients’ behaviors and communication 
about HPV and cervical cancer prevention. Despite this, these providers offer a unique view 
into this group of young adult women who they serve on a daily basis. As noted earlier, this 
geographic area suffers from high cervical cancer rates and low vaccine uptake and 
adherence rates, and these providers’ previously unheard voices shed light on important 
issues that may help to address these public health problems.
In summary, this qualitative follow-up study sought to understand health care providers’ 
perspectives on previously documented low HPV vaccine uptake and adherence rates in 
their young adult female patient population. The results offer important, practical 
implications from nursing professionals and a physician in a medically underserved region 
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of the country recognized for cervical cancer disparities that can be readily applied to other 
communities. As articulated by these Appalachian Kentucky health care providers, nurses 
and physicians need to be proactive and creative in their efforts to educate young women 
about HPV, its related health consequences, and the value of the full vaccine series. In 
addition, messages about the HPV vaccine need tailoring to the unique characteristics of 
their patient population. The design, testing, and evaluation of region- and age-specific HPV 
vaccine education and promotion strategies, which are informed by health care provider 
input, is an area ripe for future research. Participants in this study also provided tangible 
examples of clinic-oriented strategies that could facilitate improved vaccine receipt and 
compliance, but these strategies deserve further research related to feasibility, 
implementation, and vaccination outcomes. Nursing professionals should serve as key 
stakeholders in developing and implementing such clinic-oriented interventions, which if 
proven successful, could be adopted by other health care providers in similar rural and 
underserved areas.
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Figure 1. Line Graph Originated by Crosby et al. (2011)
Note: This line graph was presented to the clinicians as a topic of discussion during the in-
depth interviews. Data represents initial uptake of dose 1 of the vaccine among those women 
recruited from the rural, FQHC, as well as subsequent receipt of doses 2 and 3. HPV vaccine 
receipt was tracked using redeemed free vouchers. While doses 2 and 3 should be given at 2 
and 6 months, respectively, from dose 1, the intervention allowed for three extra months at 
each time point. Despite this time allowance and provision of free vaccine, the rates are 
strikingly low.
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